{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:43:12Z","timestamp":1790707392787,"version":"4.1.0"},"reference-count":29,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.2217\/fon.15.62","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T15:57:29Z","timestamp":1433433449000},"page":"1659-1664","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":39,"title":["Belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma"],"prefix":"10.1080","volume":"11","author":[{"given":"Armin","family":"Rashidi","sequence":"first","affiliation":[{"name":"Division of Oncology,Washington University School of Medicine,\r660 S Euclid Avenue, Campus Box 8007,\rSt Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda F","family":"Cashen","sequence":"additional","affiliation":[{"name":"Division of Oncology,Washington University School of Medicine,\r660 S Euclid Avenue, Campus Box 8007,\rSt Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-231548"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.11.009"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270785"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.11.002"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.79"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.2719"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.11.001"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.04.004"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.137937"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175371"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.4161\/15592294.2014.971580"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1369\/0022155413506582"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2009.03290.x"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-025999"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.2434"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-312603"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.4223"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.212035"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1786"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054522"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01102.x"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13222"},{"issue":"15","key":"e_1_3_3_25_1","article-title":"Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R\/R PTCL): results from the BELIEF trial","volume":"31","author":"O\u2019Connor OA","year":"2013","unstructured":"O\u2019Connor OA , MassziT, SavageKJet al. Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R\/R PTCL): results from the BELIEF trial. J. Clin. Oncol.31 (15S) (2013).","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"e_1_3_3_26_1","article-title":"A Phase I study of oral belinostat (PXD101) in patients with advanced solid tumors","volume":"25","author":"Kelly WK","year":"2007","unstructured":"Kelly WK , YapT, LeeJet al. A Phase I study of oral belinostat (PXD101) in patients with advanced solid tumors. J. Clin. Oncol.25(18S) (2007).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1419-5"},{"issue":"15","key":"e_1_3_3_28_1","article-title":"Final results of a Phase I study of oral belinostat (PXD101) in patients with lymphoma","volume":"27","author":"Zain JM","year":"2009","unstructured":"Zain JM , FossF, KellyWKet al. Final results of a Phase I study of oral belinostat (PXD101) in patients with lymphoma. J. Clin. Oncol.27 (15S) (2009).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3075.3075"},{"key":"e_1_3_3_30_1","unstructured":"BELEODAQ. www.sppirx.com."},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0275-8"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.15.62","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:20Z","timestamp":1719124940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.15.62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.2217\/fon.15.62"],"URL":"https:\/\/doi.org\/10.2217\/fon.15.62","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-06-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}